Our Weekly Update

Listen Now
National Center for Biotechnology Information
Wearables for early detection of atrial fibrillation and timely referral for Indigenous people ≥55 years: mixed-methods protocol
Introduction: Digital health technologies have the potential to provide cost-effective care to remote and underserved populations. T...
Variation in patterns of second primary malignancies across U.S. race and ethnicity groups: a Surveillance, Epidemiology, and End Results (SEER) an...
Purpose: One in six incident cancers in the U.S. is a second primary cancer (SPC). Although primary cancers vary considerably by rac...
Facilitators to cervical cancer screening in a minority, urban, underserved population
Objectives: Cervical cancer has markedly declined due to widespread use of screening, but Hispanic women continue to bear a dispropo...
Changes in dental visits and oral health for children by race and ethnicity during the COVID-19 pandemic
Background: The COVID-19 pandemic created new barriers to oral health care, which may worsen oral health and exacerbate disparities....
Latina immigrants' breast and colon cancer causal attributions: genetics is key
doi: 10.1007/s12687-023-00681-9. Online ahead of print. Affiliations Expand ...
HIV Prevention and Care Among Black Cisgender Sexual Minority Men and Transgender Women: Protocol for an HIV Status-Neutral Cohort Study Using an O...
Background: Black cisgender gay, bisexual, and other sexual minority men (SMM) and transgender women (TW) continue to be heavily aff...

Trending Topics

Features

Download and distribute powerful vaccination QI resources for your community.

Sign up now to support health equity and sustainable health outcomes in your community.

MCED tests use a simple blood draw to screen for many kinds of cancer at once.

FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.

Discover an honest look at our Medicare system.

ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.

The single most important purpose of our healthcare system is to reduce patient risk for an acute event.